-
601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours2020 Annals of Oncology article Medicine Cancer-related Molecular Pathways Open access cited by 2 patents
Hans A. J. Gelderblom, Jourik A. Gietema, Ingrid M.E. Desar, N.M. Ajmone, Mathilde Jalving, Judith R. Kroep, +5 more
5citations -
1509P Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion2022 Annals of Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Jean‐Yves Blay, H. Gelderblom, P. Rutkowski, A. Wagner, Meike van de Sande, A. Falcon Gonzalez, +13 more
5citations -
133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
V.C.G. Tjan-Heijnen, S.W.M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
5citations -
1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)2022 Annals of Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, I. Demedts, E. Pons-Tostivint, B. Biesma, F. Borm, B. Colinet, +14 more
5citations -
2O Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Alba Llop‐Guevara, Valentina A. Vladimirova, Andreas Schneeweiß, Guillermo Javierre Villacampa, Thomas Karn, D-M. Zahm, +14 more
4citations -
1623MO Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I study
Filip Jankú, Ping Chi, Michael Charles Heinrich, Margaret von Mehren, Robin L. Jones, Kristen N. Ganjoo, +9 more
4citations -
476P First-in-human, dose-escalation phase I trial of intratumoral (IT) CyPep-1 in patients (pts) with advanced solid tumors2022 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
F. A. L. M. Eskens, F. Opdam, E. Gort, H. Gelderblom, L. Prestegarden, C. Pico-Navarro
4citations -
878P Final results of a phase II study of peltopepimut-S and cemiplimab in patients with relapsed/metastatic HPV16+ oropharyngeal cancer that progressed with prior anti-PD-1 therapy
Anthony H. Kong, Caroline Even, Begoña Aguilera, Marielle Klein Hesselink, Sonja Visscher, J.C. Park, +9 more
4citations -
1260TiP The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: A randomized multi-center study in resectable HER2 overexpressing adenocarcinoma of the esophagus or gastroesophageal junction (TRAP-2)
D. Blangé, Maarten C.C.M. Hulshof, Mark I. van Berge Henegouwen, Bianca Mostert, Marije Slingerland, N. Haj Mohammad, +14 more
4citations -
LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Susana N. Banerjee, P.B. Ottevanger, Apostolos Sarivalasis, Romuald Le Scodan, Ana Montes, Judith R. Kroep, +9 more
4citations -
475P Safety and efficacy of vimseltinib in tenosynovial giant cell tumour (TGCT): Long-term phase I update2022 Annals of Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access cited by 12 patents
Hans A. J. Gelderblom, Albiruni Abdul Razak, Javier Martín‐Broto, Breelyn Ann Wilky, Piotr Lukasz Rutkowski, Supraja Narasimhan, +5 more
3citations -
LBA61 Early discontinuation of anti-PD-1 therapy upon achieving a complete or partial response in patients with metastatic melanoma: The multicentre prospective Safe Stop Trial
Karlijn de Joode, Evalyn E.A.P. Mulder, John B.A.G. Haanen, Karijn P.M. Suijkerbuijk, M. J. Boers‐Sonderen, H.M. Westgeest, +14 more
3citations -
1486MO The synovial and systemic pharmacokinetics and pharmacodynamics of intra-articular administration of the CSF1 receptor antibody AMB-05X in a phase II proof-of-concept trial in tenosynovial giant cell tumor2022 Annals of Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Hans A. J. Gelderblom, M. Huang, Michiel A. J. van de Sande, Thomas J. Scharschmidt, O.A. Kostogryz, L. Alani, +2 more
3citations -
1629MO First-line chemotherapy (CT) in advanced well-differentiated/dedifferentiated liposarcoma (WD/DD LPS): An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
Silvia Stacchiotti, W. Van der Graaf, H. Doms, Roberta G. Sanfilippo, Sandrine I. Marreaud, Winan J. van Houdt, +4 more
3citations